Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Safe Supply Streaming Portfolio Company Safety Strips, Provides Corporate Update (click to learn more) Saturn Oil & Gas Inc. Announces $525 Million Accretive Core-Area Saskatchewan Asset Acquisition (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Anavex Life Sciences Corp AVXL

Healthcare Biotechnology
Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company. The Company is engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system (CNS) diseases with unmet need. The Company analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of... see more

NDAQ:AVXL - Post Discussion

Anavex Life Sciences Corp > End of Month - September 2020
View:
Post by R_J_ on Dec 02, 2020 5:04pm

End of Month - September 2020

End of the Month (EOM) report for November 2020 for Anavex Life Sciences Corp.
-
AVXL closed on 10/30/2020 at US$5.33
AVXL closed on 10/30/2020 at US$5.90
-
This is a 9.7%, a US$O.57, Loss for November.
-
S&P 500 Index, @ 3621.63 gained 10.8% in November. [14.9% above its MA(200) @ 3152.9]
-
Two Hundred Day Moving Average [MA(200)] stuff.
AVXL's  MA(200) ended November at $4.21
AVXL is now 22.6% above its MA(200).
-
News Releases on the AVXL Website in November
-
Use this link to see and read the all of November’s News Releases.
-
https://www.anavex.com/2020/11/
https://www.anavex.com/2020/11/
-
Who is the Big Cheese at AVXL?
Christopher U. Missling, PhD, President & CEO
-
RJ
Be the first to comment on this post
Anavex Life Sciences Corp